Cargando…
COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes
Autores principales: | Lattenist, R., Yildiz, H., De Greef, J., Bailly, S., Yombi, J.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339791/ https://www.ncbi.nlm.nih.gov/pubmed/32837052 http://dx.doi.org/10.1007/s12288-020-01318-4 |
Ejemplares similares
-
COVID-19 outcomes in patients with hematologic disease
por: Malard, Florent, et al.
Publicado: (2020) -
Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India
por: Jain, Arihant, et al.
Publicado: (2022) -
In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022) -
Characteristics of pathogens detected in adults with hematological malignancies and nosocomial infections in the tropics
por: Dou, Li-Ping, et al.
Publicado: (2020) -
Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease
por: Ikeda, Daisuke, et al.
Publicado: (2023)